A patient with type 2 diabetes and stage 3 CKD (eGFR 35 mL/min) is currently on metformin 1000 mg twice daily. What is the most appropriate action?
-
A
Continue metformin at the current dose
-
B
Reduce metformin dose and monitor eGFR closely
-
C
Discontinue metformin immediately
-
D
Switch to metformin extended-release only